North America and Europe Lead Global Pharmaceutical CDMO Market Amid Regulatory Strength and Innovation Ecosystems
The global pharmaceutical contract development & manufacturing organization (CDMO) market, valued at USD 192.19 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 8.11% through 2034, driven by intensifying regional disparities in regulatory frameworks, supply chain localization mandates, and strategic capacity reallocation. North America continues to dominate...
0 Reacties
0 aandelen